| Name | Title | Contact Details |
|---|
Ballard Brands formed in December 2001 by brothers Paul, Scott and Steve Ballard. It is a privately held, multi-branded restaurant, food and coffee company, based out of New Orleans, Louisiana. We own, operate and franchise restaurants in our portfolio across the United States and in multiple countries world-wide. These brands collectively total nearly 200 locations in both traditional and non-traditional models, and continue to grow.
Physician Developed Vitamin D Enhanced Water with Electrolytes, Antioxidants and Zero Sugar.
Try crispy-filled delicious Rösti anytime, anyway! 3 Delicious flavors: stuffed baked potato, zesty chili cheese and melty swiss raclette by ÜRÖSTI.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.